Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003)-Reference-Cited by-同舟云学术

Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003)

Published:2020-11-28 Issue:1 Volume:5 Page:75-82
ISSN:2475-0328
Container-title:Annals of Gastroenterological Surgery
language:en
Short-container-title:Ann. Gastroenterol. Surg.

Author:

Sugimura Keijiro¹^ORCID,Yamasaki Makoto²,Yasuda Takushi³,Yano Masahiko¹,Hirao Motohiro⁴,Fujitani Kazumasa⁵,Kimura Yutaka³^ORCID,Miyata Hiroshi¹,Motoori Masaaki⁵,Takeno Atsushi⁶,Shiraishi Osamu³,Makino Tomoki²^ORCID,Kii Takayuki⁷,Tanaka Koji²,Satoh Taro⁸,Mori Masaki⁹,Doki Yuichiro²

Affiliation:

1. Department of Surgery Osaka International Cancer Institute Osaka Japan

2. Departments of Gastroenterological Surgery Graduate School of Medicine Osaka University Suita Japan

3. Department of Surgery Kinki University Faculty of MedicineOsaka Sayama Osaka Japan

4. Department of Surgery National Hospital Organization Osaka National Hospital Osaka Japan

5. Department of Surgery Osaka General Medical Center Osaka Japan

6. Department of Surgery Kansai Rosai Hospital Hyogo Japan

7. Cancer Chemotherapy Center Osaka Medical College Hospital Osaka Japan

8. Department of Frontier Science for Cancer and Chemotherapy Osaka University Graduate School of Medicine Suita Japan

9. Department of Surgery and Science Graduate School of Medical Sciences Kyusyu University Fukuoka Japan

Publisher

Wiley

Subject

Gastroenterology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ags3.12388

Reference23 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma

3. Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta‐analysis

4. Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis

5. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of time to postoperative recurrence on the prognosis of patients with esophageal cancer post recurrence: exploratory analysis of OGSG 1003;Esophagus;2024-08-22

2. Association between fibrosis around the tumor and postoperative infectious complication in patients with esophageal cancer who underwent preoperative therapy;World Journal of Surgery;2024-02-06

3. Clinical Impact of Conversion Surgery After Induction Therapy for Esophageal Cancer with Synchronous Distant Metastasis: A Multi-institutional Retrospective Study;Annals of Surgical Oncology;2024-02-01

4. Indications for neoadjuvant chemotherapy in older patients undergoing esophagectomy for esophageal cancer;Surgery Today;2023-10-31

5. Long-term survival and prognostic factors associated with curative conversion surgery for ct4b esophageal squamous cell carcinoma: Analysis of 200 consecutive cases;Surgery;2023-09